Interpreting Positive and Inverse Disproportionality Signals in Spontaneous Reporting Systems: A Claim-Strength Framework with Direction-Aware Evaluation
{"Disproportionality":[0],"analysis":[1],"of":[2,59,96,135,173,191,229,263],"spontaneous":[3],"reporting":[4,31,89,204],"systems":[5],"is":[6,90,168],"usually":[7],"used":[8],"to":[9,84,113,196,257],"identify":[10],"positive":[11,104,197],"signals,":[12],"meaning":[13],"drug-event":[14],"pairs":[15],"reported":[16,239],"more":[17],"often":[18],"than":[19],"expected.":[20],"The":[21,80],"same":[22,81,115,137],"statistical":[23],"structure":[24],"also":[25,194,209,245],"has":[26],"a":[27,74,184,211],"lower-reporting":[28],"side.":[29],"A":[30],"odds":[32],"ratio":[33],"(ROR)":[34],"above":[35],"unity":[36,44],"indicates":[37,45],"higher-than-expected":[38],"reporting,":[39],"whereas":[40],"an":[41],"ROR":[42,67,85],"below":[43],"lower-than-expected":[46,241],"reporting.":[47,242],"Neither":[48],"result":[49],"directly":[50],"estimates":[51],"incidence,":[52],"absolute":[53],"risk,":[54],"or":[55,77,159,205,249,265],"causality.":[56],"Existing":[57],"critiques":[58,190],"inverse":[60,106,192,235],"disproportionality":[61,107],"signals":[62,108,193,198,236],"rightly":[63],"warn":[64],"against":[65],"interpreting":[66],"<":[68],"1":[69],"as":[70,240],"protection,":[71],"risk":[72,266],"reduction,":[73],"beneficial":[75],"reaction,":[76],"therapeutic":[78],"effect.":[79],"caution":[82],"applies":[83],">":[86],"1.":[87],"Higher-than-expected":[88],"not,":[91],"by":[92],"itself,":[93],"causal":[94,206],"evidence":[95,141,218],"harm.":[97],"This":[98,118],"narrative":[99],"methodological":[100],"review":[101,182],"argues":[102],"that":[103,133,167,187],"and":[105,199,259],"should":[109],"be":[110,238],"interpreted":[111],"according":[112],"the":[114,136,171,174,181,216,221,227,230],"scientific":[116,130],"principles.":[117],"does":[119,146],"not":[120,147,225],"imply":[121],"symmetric":[122],"regulatory":[123,157],"action":[124],"thresholds.":[125],"In":[126],"this":[127,178,233],"review,":[128],"\\"symmetric":[129],"standards\\"":[131],"means":[132],"claims":[134],"strength":[138,172],"require":[139,268],"commensurate":[140],"in":[142,214],"both":[143],"directions;":[144],"it":[145,163],"mean":[148],"identical":[149],"case-level":[150],"information,":[151],"bias":[152],"mechanisms,":[153],"detectability,":[154],"predictive":[155],"value,":[156],"priority,":[158],"follow-up":[160,253],"procedures.":[161],"Instead,":[162],"calls":[164],"for":[165,252],"interpretation":[166],"consistent":[169],"with":[170],"claim.":[175],"To":[176],"make":[177],"approach":[179],"practical,":[180],"outlines":[183],"symmetry":[185],"check":[186],"asks":[188],"whether":[189,200],"apply":[195],"they":[201],"address":[202],"descriptive":[203],"interpretation.":[207],"It":[208],"proposes":[210],"claim-strength":[212],"framework":[213],"which":[215],"required":[217],"depends":[219],"on":[220,226],"claim":[222],"being":[223],"made,":[224],"direction":[228],"signal.":[231],"Under":[232],"approach,":[234],"may":[237,244],"They":[243],"support":[246],"hypothesis":[247],"generation":[248],"candidate":[250],"prioritization":[251],"evaluation":[254],"when":[255],"robust":[256],"comparator":[258],"sensitivity":[260],"analyses.":[261],"Claims":[262],"protection":[264],"reduction":[267],"external":[269],"validation.":[270]}
Authors
- Yoshihiro Uesawa (ORCID: https://orcid.org/0000-0002-5773-991X)
Institutions
- Meiji Pharmaceutical University (JP)
Publication Details
- Journal
- Drug Safety
- Published
- 2026-09-17
- DOI
- https://doi.org/10.1007/s40264-026-01726-x
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00